{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:59:12Z","timestamp":1759341552092,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.cbi.2010.11.008","type":"journal-article","created":{"date-parts":[[2010,11,26]],"date-time":"2010-11-26T04:12:48Z","timestamp":1290744768000},"page":"177-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations"],"prefix":"10.1016","volume":"189","author":[{"given":"Patricia","family":"Rivest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Thomas Sanderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cbi.2010.11.008_bib0005","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chembiol.2003.11.010","article-title":"GSK-3-selective inhibitors derived from Tyrian purple indirubins","volume":"10","author":"Meijer","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cbi.2010.11.008_bib0010","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/cber.190904201122","article-title":"Uber den Farbstoff des antiken Purpurs aus Murex brandaris","volume":"42","author":"Friedlander","year":"1909","journal-title":"Ber. Dtsch. Chem. Ges."},{"issue":"9","key":"10.1016\/j.cbi.2010.11.008_bib0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","article-title":"Pharmacological inhibitors of glycogen synthase kinase 3","volume":"25","author":"Meijer","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.cbi.2010.11.008_bib0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0165-6147(02)02071-0","article-title":"Pharmacological inhibitors of cyclin-dependent kinases","volume":"23","author":"Knockaert","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"22","key":"10.1016\/j.cbi.2010.11.008_bib0025","doi-asserted-by":"crossref","first-page":"15469","DOI":"10.1074\/jbc.M707238200","article-title":"Differential modulation of Akt\/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses","volume":"283","author":"Nair","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.cbi.2010.11.008_bib0030","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1016\/j.bmc.2008.04.003","article-title":"Synthesis of indirubin-N\u2032-glycosides and their anti-proliferative activity against human cancer cell lines","volume":"16","author":"Libnow","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"17","key":"10.1016\/j.cbi.2010.11.008_bib0035","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1073\/pnas.0409467102","article-title":"Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells","volume":"102","author":"Nam","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.cbi.2010.11.008_bib0040","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.bcp.2008.01.021","article-title":"Critical role of Bid and Bax in indirubin-3\u2032-monoxime-induced apoptosis in human cancer cells","volume":"75","author":"Shi","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.cbi.2010.11.008_bib0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mc.10114","article-title":"Alsterpaullone, a novel cyclin-dependent kinase inhibitor, induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potential","volume":"36","author":"Lahusen","year":"2003","journal-title":"Mol. Carcinog."},{"issue":"15","key":"10.1016\/j.cbi.2010.11.008_bib0050","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1021\/jm9900570","article-title":"Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1\/cyclin B inhibition, and in vitro antitumor activity","volume":"42","author":"Schultz","year":"1999","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.cbi.2010.11.008_bib0055","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1080\/1042819021000006295","article-title":"Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China","volume":"43","author":"Xiao","year":"2002","journal-title":"Leuk. Lymphoma"},{"issue":"11","key":"10.1016\/j.cbi.2010.11.008_bib0060","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1210\/endo.142.11.8467","article-title":"Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state","volume":"142","author":"Murillo","year":"2001","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cbi.2010.11.008_bib0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.pcan.4500794","article-title":"Wnt signalling and prostate cancer","volume":"8","author":"Yardy","year":"2005","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"3","key":"10.1016\/j.cbi.2010.11.008_bib0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.onc.1209020","article-title":"PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer","volume":"25","author":"Mulholland","year":"2006","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cbi.2010.11.008_bib0075","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1210\/en.2003-1519","article-title":"Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer","volume":"145","author":"Liao","year":"2004","journal-title":"Endocrinology"},{"issue":"31","key":"10.1016\/j.cbi.2010.11.008_bib0080","doi-asserted-by":"crossref","first-page":"32444","DOI":"10.1074\/jbc.M313963200","article-title":"Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.cbi.2010.11.008_bib0085","doi-asserted-by":"crossref","first-page":"9918","DOI":"10.1158\/0008-5472.CAN-08-1718","article-title":"Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer","volume":"68","author":"Wang","year":"2008","journal-title":"Cancer Res."},{"issue":"41","key":"10.1016\/j.cbi.2010.11.008_bib0090","doi-asserted-by":"crossref","first-page":"27707","DOI":"10.1074\/jbc.M802759200","article-title":"Regulation of Akt\/FOXO3a\/GSK-3beta\/AR signaling network by isoflavone in prostate cancer cells","volume":"283","author":"Li","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.cbi.2010.11.008_bib0095","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1038\/sj.onc.1209366","article-title":"Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells","volume":"25","author":"Yang","year":"2006","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.cbi.2010.11.008_bib0100","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1210\/er.2003-0034","article-title":"Interaction of nuclear receptors with the Wnt\/beta-catenin\/Tcf signaling axis: Wnt you like to know?","volume":"26","author":"Mulholland","year":"2005","journal-title":"Endocr. Rev."},{"issue":"17","key":"10.1016\/j.cbi.2010.11.008_bib0105","first-page":"4709","article-title":"Beta-catenin affects androgen receptor transcriptional activity and ligand specificity","volume":"60","author":"Truica","year":"2000","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cbi.2010.11.008_bib0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/toxsci\/66.1.69","article-title":"A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists","volume":"66","author":"Wilson","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2010.11.008_bib0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"issue":"19","key":"10.1016\/j.cbi.2010.11.008_bib0120","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1046\/j.1432-1327.2000.01673.x","article-title":"Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5\/p25","volume":"267","author":"Leost","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"20","key":"10.1016\/j.cbi.2010.11.008_bib0125","doi-asserted-by":"crossref","first-page":"14566","DOI":"10.1016\/S0021-9258(17)36661-9","article-title":"Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine\/threonine phosphorylation","volume":"269","author":"Wang","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cbi.2010.11.008_bib0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4161\/cc.1.2.112","article-title":"CDK inhibitors: cell cycle arrest versus apoptosis","volume":"1","author":"Schwartz","year":"2002","journal-title":"Cell Cycle"},{"issue":"12","key":"10.1016\/j.cbi.2010.11.008_bib0135","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.cbi.2010.11.008_bib0140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bmcl.2003.10.062","article-title":"1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta","volume":"14","author":"Kunick","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"25","key":"10.1016\/j.cbi.2010.11.008_bib0145","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1038\/sj.onc.1207535","article-title":"Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins","volume":"23","author":"Knockaert","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2010.11.008_bib0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2121-9-4","article-title":"The androgen receptor can signal through Wnt\/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens","volume":"9","author":"Schweizer","year":"2008","journal-title":"BMC Cell Biol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710006356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710006356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:23:13Z","timestamp":1757856193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279710006356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0009279710006356"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2010.11.008","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2010.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}